Literature DB >> 4131033

Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.

R G Henderson, R G Russell, J G Ledingham, R Smith, D O Oliver, R J Walton, D G Small, C Preston, G T Warner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4131033     DOI： 10.1016/s0140-6736(74)93149-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  37 in total

1.  Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.

Authors:  J A Kanis; R G Henderson; G Heynen; J G Ledingham; R G Russell; R Smith; R J Walton
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

2.  1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.

Authors:  A M Pierides; H A Ellis; H Dellagrammatikas; J E Scott; A W Norman
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

3.  Effects of 1,25-dihydroxycholecalciferol on calcium and phosphorus metabolism in hypoparathyroidism.

Authors:  M Davies
Journal:  Calcif Tissue Res       Date:  1977-05

4.  The treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.

Authors:  B J Junor; G R Catto; M Macleod
Journal:  Calcif Tissue Res       Date:  1977-05

5.  Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol.

Authors:  P Vergne-Marini; T F Parker; C Y Pak; A R Hull; H F DeLuca; J S Fordtran
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

6.  Effect of I,25-dihydroxycholecalciferol in renal osteodystrophy.

Authors:  D S Silverberg; K B Bettcher; J B Dossetor; T R Overton; M F Holick; H F DeLuca
Journal:  Can Med Assoc J       Date:  1975-01-25       Impact factor: 8.262

7.  Effects of vitamin D3 metabolites on calcium fluxes in intact chicken skeletal muscle and myoblasts cultured in vitro.

Authors:  D L Giuliani; R L Boland
Journal:  Calcif Tissue Int       Date:  1984-03       Impact factor: 4.333

8.  Significance of serum level of 25-hydroxycholecalciferol in gastrointestinal disease.

Authors:  M S Schoen; J Lindenbaum; M S Roginsky; P R Holt
Journal:  Am J Dig Dis       Date:  1978-02

9.  Parenteral 1,25-dihydroxycholecalciferol in hepatic osteomalacia.

Authors:  R G Long; Z Varghese; E A Meinhard; R K Skinner; M R Wills; S Sherlock
Journal:  Br Med J       Date:  1978-01-14

Review 10.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.